Mark Douglas Smith - 21 May 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Reporting relationship: Director
Issuer ticker: TDOC
Reported as of: 21 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 May 2026, 17:14:28 UTC
Prior SEC filing: 11 Aug 2025
Next SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Adam C. Vandervoort, Attorney-in-Fact

Key filing fact

Mark Douglas Smith filed Form 4 for Teladoc Health, Inc. (TDOC) on 21 May 2026.

Key facts

This page summarizes Mark Douglas Smith's Form 4 filing for Teladoc Health, Inc. (TDOC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 May 2026, 17:14.

Change

Previous filing in this sequence was filed on 11 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001756253 Primary reporting owner

Smith Mark Douglas

Relationship: Director
Address: C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Signature date: 21 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +30,441
Change %
Price: $0.000000^*
Shares after: 30,441
Date: 21 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,441
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

Footnote F2

The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.